Antibodies against human CCN1 and uses thereof

Disclosed herein are methods for the recombinant expression of mammalian cell membrane-bound human CCN1 or a CCN1 domain thereof in mammalian cells, comprising transforming a mammalian host cell with a vector encoding CCN1 or a CCN1 domain thereof C-terminally fused to a mammalian cell transmembrane...

Full description

Saved in:
Bibliographic Details
Main Authors Knoetgen, Hendrik, Krell, Hans-Willi, Miller, Sandra, Niewoehner, Jens, Ponsel, Dirk, Toksoez, Engin
Format Patent
LanguageEnglish
Published 26.06.2012
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are methods for the recombinant expression of mammalian cell membrane-bound human CCN1 or a CCN1 domain thereof in mammalian cells, comprising transforming a mammalian host cell with a vector encoding CCN1 or a CCN1 domain thereof C-terminally fused to a mammalian cell transmembrane domain (CCN1 fusion protein), expressing said CCN1 or CCN1 domain fusion protein in said host cell, and recovering said membrane bound CCN1 or said CCN1 domain thereof. Disclosed herein is the use of such membrane bound CCN1 and domain for the generation of corresponding antibodies. Antibodies against human CCN1 are useful for the treatment of diseases.